News & Analysis on Clinical Trial Services & Contract Research And Development
Accelrys are to expand its Discovery Studio software environment with new and enhanced life science modelling and simulation functionality, which is set to deliver a broader range of tools for drug discovery in one environment.
A discovery made by scientists has pointed to a brighter future in the development of drugs to more effectively target, treat and possibly even prevent inherited and non-inherited thyroid cancers.
Pharmaceutical company Eli Lilly, has been asked to justify its decision to outsource its animal testing to countries with no or poor animal welfare standards, which go against Lilly's commitment to reducing, refining, and replacing its use of animals.
Metabolex, has received its first European patent for metaglidasen (MBX-102), the company's lead drug candidate for treating type 2 diabetes, insulin resistance, impaired glucose tolerance and obesity.
The US government to pass new measures that make prosecuting animal-rights activists who target enterprises much easier. The move has lead critics to warn that peaceful demonstrators would be labelled as terrorists.